Physician profile
Karl A Bergmann
NPI 1447497649
$12,473.57
in general payments reported to CMS, 2019-2025
43 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $1,036 · 2021: $1,607 · 2022: $3,218 · 2023: $1,321 · 2024: $2,828 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,251 · Travel and Lodging: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,251.32 |
| Travel and Lodging | $1,393.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,901.06 | 2019-2025 | Pangea, Actishield, Gamma |
| Si-Bone, INC. | $1,523.92 | 2021-2025 | |
| Musculoskeletal Transplant Foundation INC. | $1,207.91 | 2021-2023 | |
| Arthrex, INC. | $1,065.71 | 2022-2024 | Distal Extremities Implants Trauma Ankle Fracture |
| Conetic Solutions, INC. | $979.10 | 2021-2025 | |
| Depuy Synthes Sales INC. | $671.76 | 2019-2025 | Va-Lcp, Fibergraft Aeridyan Matrix |
| Zimmer Biomet Holdings, INC. | $503.44 | 2019-2023 | Znn |
| Ethicon US, LLC | $328.03 | 2020-2023 | Ethicon, Vicryl, Stratafix |
| Globus Medical, INC. | $286.86 | 2021-2025 | Anthem |
| US Implant Solutions, LLC | $242.86 | 2021 | |
| Smith+Nephew, INC. | $228.47 | 2019-2023 | Evos Mini, Evos |
| Curvafix, INC. | $176.00 | 2022 | |
| Biocomposites INC | $170.90 | 2020-2021 | |
| Innovation Technologies INC | $119.70 | 2021 | |
| Orthogrid Systems INC | $109.32 | 2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $108.22 | 2024-2025 | Isturisa, Signifor Lar |
| Osteocentric Technologies, INC. | $85.00 | 2022 | |
| Integra Lifesciences Corporation | $82.62 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Chiesi USA, INC. | $71.77 | 2024-2025 | Mycapssa |
| Radius Health, INC. | $55.50 | 2023-2025 | Tymlos |
| Polynovo North America LLC | $52.93 | 2022-2023 | |
| Sanara Medtech INC. | $50.92 | 2024-2025 | Celleraterx, Celleraterx |
| Becton, Dickinson and Company | $45.45 | 2025 | Arista |
| Xeris Pharmaceuticals, INC. | $42.41 | 2022-2023 | Gvoke Hypopen |
| Kyowa Kirin, INC. | $36.56 | 2023-2024 | Crysvita |
| Orthofix Medical, INC. | $29.80 | 2019-2023 | Physio-Stim |
| Spr Therapeutics, INC | $23.97 | 2022 | |
| Bioventus LLC | $22.75 | 2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $22.67 | 2023 | Tepezza |
| Ermi LLC | $22.67 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.39 | 2023 | |
| Mallinckrodt Enterprises LLC | $18.54 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.51 | 2022 | |
| Ascensia Diabetes Care US INC. | $17.35 | 2024 | |
| Insulet Corporation | $15.99 | 2023 | Omnipod |
| Lifenet Health | $15.75 | 2024 | Theragenesis Wound Matrix |
| Amryt Pharma Holdings LTD | $15.43 | 2023 | Mycapssa |
| Solventum Corporation | $15.25 | 2025 | V.A.C. Veraflo, Prevena, Activ.A.C. |
| Lilly USA, LLC | $14.64 | 2024 | Zepbound |
| Scilex Pharmaceuticals INC. | $14.49 | 2019 | |
| Medtronic, INC. | $14.05 | 2023 | Intellis Adaptivestim |
| Melinta Therapeutics, LLC | $12.84 | 2020 | |
| Pfizer INC. | $12.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Bergmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.